University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 15 of 23
Mothers and Others: Family-based Obesity Prevention for Infants and Toddlers
NCT01938118
Effect of Sulforaphane-rich Broccoli Sprout Homogenate on Ozone Induced Inflammation Through Modulation of NRF2
NCT01625130
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
NCT01615484
Study of Wellness Behaviors as a Function of Oxytocin vs Placebo
NCT01929161
A Transgenerational e-Intervention for Gestational Diabetics and Their Offspring
NCT01931280
Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
NCT01732718
Wellness Intervention for Menstrual Mood Disorders
NCT01995916
Can a Rapid 2 Day Followup After Discharge From the ED Reduce Readmissions and Death for Patients 75 Years and Older?
NCT01769495
Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study
NCT01938157
Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition
NCT01762943
Use of a Brief Phone Call After ED Discharge
NCT01893931
Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy
NCT01900418
Study of Exposure to Stress, Postpartum Mood, Adverse Life Events, and Hormonal Function Among Latinas (SEPAH Latina)
NCT01912833
Padres Efectivos (Parent Activation): Skills Latina Mothers Use to Get Healthcare for Their Children
NCT02329431
Determining the Barriers and Motivations to Clinical Trial Participation
NCT01937091
Nutritional Supplementation Effects on Rehabilitation Outcomes in Rotator Cuff Pathology
NCT01798693
Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania
NCT01865383
Observational Assessment of Baseline Asthma Control in African-American Children
NCT01891630
Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma
NCT01912599
Shoe Lifts for Leg Length Inequality in Adults With Knee or Hip Symptoms
NCT01894100
Fluid Intake Application to Reduce Kidney Stone Risks
NCT01928108
Rethinking Eating and FITness for Men
NCT01843595
Anorexia Nervosa Genetics Initiative
NCT01916538
The Effect of Anticholinergics on Cognitive Function in the Elderly
NCT01922115
Factors Affecting PrEP Adherence
NCT02411630
Brief Intervention to Create Smoke-Free Homes Policies in Low-Income Households: North Carolina Effectiveness Trial
NCT01868672
chemQbiosciences:Manual Liquid Based Cytology
NCT01837303
Prophylactic Modified McCall Culdoplasty During Total Laparoscopic Hysterectomy
NCT01840176
Control of Tourniquet Pain With an Axillary Ring of Subcutaneous Local Anesthetic
NCT01829399
Sulforaphane Supplementation in Atopic Asthmatics
NCT01845493
Keys to Healthy Family Child Care Homes
NCT01814215
Mechanisms of Desensitization During Peanut Oral Immunotherapy
NCT01814241
Accountability for Cancer Care Through Undoing Racism and Equity
NCT01954641
Technology to Enhance Treatment for Early Conduct Problems in Low Income Families
NCT02191956
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
NCT01769456
Feasibility of Using a Structured Daily Diary
NCT01953653
Pharmacokinetics of Sildenafil in Premature Infants
NCT01670136
Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis
NCT01825408
Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis
NCT01792271
Prevalence of Dysplasia of the Gastric Cardia
NCT01787864
Effect of Beta-Alanine on Heart Rate Response
NCT01745016
Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care
NCT01751620
The Pathogenesis of Hepatitis C Virus Vertical Transmission
NCT01921400
Comparing Validity of Non-Invasive Hemoglobin Monitoring to Laboratory Results in Critically Ill Children
NCT01750463
Educational-Medical-Behavioral Treatment of Fecal Incontinence
NCT01717456
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
NCT01731119
Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
NCT01769469
Nutritional Prevention of Exertional Muscle Dysfunction
NCT01722448
Effect of ASEA on Energy Expenditure and Fat Oxidation in Humans
NCT01884727
Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease
NCT01766960
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.